Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 9, 2016 - Issue 3
Submit an article Journal homepage
361
Views
9
CrossRef citations to date
0
Altmetric
Reviews

Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin: rationale and evidences

Awadhesh Kumar SinghG.D Hospital & Diabetes Institute, Kolkata, IndiaCorrespondence[email protected]
&
Ritu SinghG.D Hospital & Diabetes Institute, Kolkata, India
Pages 409-418 | Received 20 Oct 2015, Accepted 09 Dec 2015, Published online: 05 Jan 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Viswanathan Mohan, Ambrish Mithal, Shashank R Joshi, S R Aravind & Subhankar Chowdhury. (2020) Remogliflozin Etabonate in the Treatment of Type 2 Diabetes: Design, Development, and Place in Therapy. Drug Design, Development and Therapy 14, pages 2487-2501.
Read now

Articles from other publishers (8)

Dario Giugliano, Miriam Longo, Paola Caruso, Rosa Di Fraia, Lorenzo Scappaticcio, Maurizio Gicchino, Michela Petrizzo, Giuseppe Bellastella, Maria Ida Maiorino & Katherine Esposito. (2021) Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial. Diabetes Care 44:6, pages 1353-1360.
Crossref
Jianping Weng, Longyi Zeng, Yuwei Zhang, Shen Qu, Xueying Wang, Ping Li, Liujun Fu, Boqing Ma, Shandong Ye, Jiao Sun, Weiping Lu, Zhiwen Liu, Daoxiong Chen, Zhifeng Cheng, Haiyan Liu, Tao Zhang & Jianjun Zou. (2021) Henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial. Diabetes, Obesity and Metabolism.
Crossref
Awadhesh Kumar Singh & Ritu Singh. (2021) Effect of background insulin therapy on cardiovascular outcomes with SGLT-2 inhibitors in type 2 diabetes: A meta-analysis of cardiovascular outcome trials. Diabetes Research and Clinical Practice 172, pages 108648.
Crossref
Ze Chen & Gerui Li. (2019) Sodium-Glucose Co-Transporter 2 Inhibitors Compared with Sulfonylureas in Patients with Type 2 Diabetes Inadequately Controlled on Metformin: A Meta-Analysis of Randomized Controlled Trials. Clinical Drug Investigation 39:6, pages 521-531.
Crossref
A Ram Hong, Bo Kyung KooSang Wan KimKa Hee YiMin Kyong Moon. (2019) Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Korean Patients with Type 2 Diabetes Mellitus in Real-World Clinical Practice. Diabetes & Metabolism Journal 43:5, pages 590.
Crossref
B.M. Mishriky, R.J. Tanenberg, K.A. Sewell & D.M. Cummings. (2018) Comparing SGLT-2 inhibitors to DPP-4 inhibitors as an add-on therapy to metformin in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes & Metabolism 44:2, pages 112-120.
Crossref
Ana Marta de Matos, Maria Paula de Macedo & Amélia Pilar Rauter. (2018) Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential. Medicinal Research Reviews 38:1, pages 261-324.
Crossref
Huilin Tang, Wei Cui, Dandan Li, Tiansheng Wang, Jingjing Zhang, Suodi Zhai & Yiqing Song. (2017) Sodium-glucose co-transporter 2 inhibitors in addition to insulin therapy for management of type 2 diabetes mellitus: A meta-analysis of randomized controlled trials. Diabetes, Obesity and Metabolism 19:1, pages 142-147.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.